Clozapine-Induced Late Agranulocytosis and Severe Neutropenia Complicated with Streptococcus pneumonia, Venous Thromboembolism, and Allergic Vasculitis in Treatment-Resistant Female Psychosis
Clozapine is a second-generation antipsychotic agent from the benzodiazepine group indicated for treatment-resistant schizophrenia and other psychotic conditions. Using clozapine earlier on once a case appears to be refractory limits both social and personal morbidity of chronic psychosis. However t...
Saved in:
Main Authors: | Christina Voulgari, Raphael Giannas, Georgios Paterakis, Anna Kanellou, Nikolaos Anagnostopoulos, Stamata Pagoni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2015-01-01
|
Series: | Case Reports in Medicine |
Online Access: | http://dx.doi.org/10.1155/2015/703218 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Loxapine and Cyproheptadine Combined Limit Clozapine Rebound Psychosis and May Also Predict Clozapine Response
by: Lila Aboueid, et al.
Published: (2016-01-01) -
Concomitant Use of Topiramate Inducing Neutropenia in a Schizophrenic Male Stabilized on Clozapine
by: Pravesh Sharma, et al.
Published: (2016-01-01) -
Considerations of HLA, Renal Failure, Valproic Acid Use, and Current Treatment Guidelines in Clozapine-Induced Agranulocytosis
by: Melissa Sussman, et al.
Published: (2021-01-01) -
Psychosis or Obsessions? Clozapine Associated with Worsening Obsessive-Compulsive Symptoms
by: Jonathan G. Leung, et al.
Published: (2016-01-01) -
Development of Agranulocytosis after Discontinuation of Methimazole: An Unusual Case
by: Rıfkı Üçler, et al.
Published: (2015-01-01)